Evidence map›Paper›PMID 21856484›Full record

ReviewLancet (London, England)2011

In search of new therapeutic targets and strategies for heart failure: recent advances in basic science.

Ajay M Shah, Douglas L Mann

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Lancet (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03837470 (Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fraction), which is not on this map. Cited by 112 papers.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03837470 early_phase1completednot on this mapstarted 2019, after this paper: background citation

Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fraction

TypeinterventionalSponsorAdhish AgarwalRan2019 to 2020Enrolled14ConditionsHeart Failure With Preserved Ejection FractionArms0.9% Sodium Chloride, Furosemide 40 mg
3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 282 citations in OpenAlex.

  1. Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure.Clinical research in cardiology : official journal of the German Cardiac Society · 2016
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Ajay M ShahKing's College London British Heart Foundation Centre of Excellence, London, UK. ajay.shah@kcl.ac.uk
Douglas L Mann
King's College London · GBWashington University in St. Louis · US

Funding

Cardiac Inflammation in Resuscitated Hemorrhagic ShockR01HL073017 · NHLBI · WASHINGTON UNIVERSITY · PI MANN, DOUGLAS L · 2005 to 2008
$1.4M
CAUSE AND CONSEQUENCE OF TNF OVEREXPRESSION IN THE HEARTR01HL058081 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MANN, DOUGLAS LOWELL · 1998 to 2007
$1.4M
Cytoprotective Cytokine Signaling and Reperfusion InjuryR01HL089543 · NHLBI · WASHINGTON UNIVERSITY · PI MANN, DOUGLAS L · 2009 to 2010
$779k
British Heart Foundation RG/08/011/25922NHLBI NIH HHS HL089543NHLBI NIH HHS HL73017NHLBI NIH HHS R01 HL058081NHLBI NIH HHS R01 HL073017NHLBI NIH HHS R01 HL089543NHLBI NIH HHS R01 HL58081
6 · The paper itself

Abstract

Chronic heart failure continues to impose a substantial health-care burden, despite recent treatment advances. The key pathophysiological process that ultimately leads to chronic heart failure is cardiac remodelling in response to chronic disease stresses. Here, we review recent advances in our understanding of molecular and cellular mechanisms that play a part in the complex remodelling process, with a focus on key molecules and pathways that might be suitable targets for therapeutic manipulation. Such pathways include those that regulate cardiac myocyte hypertrophy, calcium homoeostasis, energetics, and cell survival, and processes that take place outside the cardiac myocyte--eg, in the myocardial vasculature and extracellular matrix. We also discuss major gaps in our current understanding, take a critical look at conventional approaches to target discovery that have been used to date, and consider new investigational avenues that might accelerate clinically relevant discovery.

Indexed as

AnimalsApoptosisCalciumChronic DiseaseCoronary CirculationExtracellular MatrixHeart FailureHumansMyocytes, CardiacSignal TransductionVentricular RemodelingCalcium

Identifiers

PMID21856484
PMCPMC3486638
OpenAlexW2003788310

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.